Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Calvez

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Microbiology|July 6, 2000
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistanceM Mouroux, A Yvon-Groussin, G Peytavin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 31, 2016
Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtypeC Soulié, D B Fofana, N Boukli, et al.
Journal of Medical Virology|March 25, 2008
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutationC Delaugerre, P Flandre, A G Marcelin, et al.
JAMA|January 14, 2000
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team)D Descamps, P Flandre, V Calvez, et al.
Pathologie-Biologie|July 27, 1999
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor]M Mouroux, P Bossi, A Yvon-Groussin, et al.
HIV Medicine|April 27, 2017
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populationsE Todesco, C Charpentier, M Bertine, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2013
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapyS Lambert-Niclot, C Charpentier, A Storto, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2016
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patientsL Bocket, G Peytavin, E K Alidjinou, et al.
Neurology|January 10, 2001
Clinical and spectroscopic improvement in HIV-associated cognitive impairmentB Stankoff, A Tourbah, S Suarez, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|July 6, 2000
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistanceM Mouroux, A Yvon-Groussin, G Peytavin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 31, 2016
Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtypeC Soulié, D B Fofana, N Boukli, et al.
Journal of Medical Virology|March 25, 2008
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutationC Delaugerre, P Flandre, A G Marcelin, et al.
JAMA|January 14, 2000
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team)D Descamps, P Flandre, V Calvez, et al.
Pathologie-Biologie|July 27, 1999
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor]M Mouroux, P Bossi, A Yvon-Groussin, et al.
HIV Medicine|April 27, 2017
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populationsE Todesco, C Charpentier, M Bertine, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2013
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapyS Lambert-Niclot, C Charpentier, A Storto, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2016
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patientsL Bocket, G Peytavin, E K Alidjinou, et al.
Neurology|January 10, 2001
Clinical and spectroscopic improvement in HIV-associated cognitive impairmentB Stankoff, A Tourbah, S Suarez, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.
Pageof 15